JWEL π Jamieson Wellness - Overview
Exchange: TO • Country: Canada • Currency: CAD • Type: Common Stock • ISIN: CA4707481046
JWEL: Vitamins, Minerals, Supplements, Probiotics, Multivitamins, Fish Oils
Jamieson Wellness Inc., together with its subsidiaries, develops, manufactures, distributes, markets, and sells of branded and customer branded health products for humans in Canada, the United States, China and internationally. It operates through two segments, Jamieson Brands and Strategic Partners. The Jamieson Brands segment manufactures, distributes, and markets branded natural health products including vitamins, minerals, and supplements. The Strategic Partners segment provides contract manufacturing services to consumer health companies and retailers. The company offers health and wellness supplements under the Jamieson brand; health, beauty, and wellness supplements under the Youtheory brand; and foundational formulas, including probiotics, multivitamins, fish oils, vitamin D, and solution-focused products for better sleep or digestion under the Progressive brand. It also provides plant-based products under the Iron Vegan brand; natural health products for health concerns among women, including hormone imbalances, nutrient deficiencies, and sleep and stress management, and others under the Smart Solutions brand; and sports nutrition supplements under the Precision brand. The company offers its contract manufacturing services under the Nurticorp brand. It sells its products to distributors, and retail and wholesale customers. The company was formerly known as Jamieson Intermediate Holdings Ltd. and changed its name to Jamieson Wellness Inc. in May 2017. Jamieson Wellness Inc. was founded in 1922 and is headquartered in Toronto, Canada. Web URL: https://www.jamiesonwellness.com
Additional Sources for JWEL Stock
JWEL Stock Overview
Market Cap in USD | 1,071m |
Sector | Consumer Defensive |
Industry | Packaged Foods |
GiC Sub-Industry | Packaged Foods & Meats |
IPO / Inception |
JWEL Stock Ratings
Growth 5y | 25.7% |
Fundamental | 52.6% |
Dividend | 68.4% |
Rel. Strength Industry | 106 |
Analysts | - |
Fair Price Momentum | 36.09 CAD |
Fair Price DCF | 25.83 CAD |
JWEL Dividends
Dividend Yield 12m | 2.14% |
Yield on Cost 5y | 3.40% |
Annual Growth 5y | 13.63% |
Payout Consistency | 100.0% |
JWEL Growth Ratios
Growth Correlation 3m | 73.6% |
Growth Correlation 12m | 72.1% |
Growth Correlation 5y | -17.5% |
CAGR 5y | 9.67% |
CAGR/Mean DD 5y | 0.57 |
Sharpe Ratio 12m | 0.88 |
Alpha | 11.00 |
Beta | 0.47 |
Volatility | 23.73% |
Current Volume | 49.5k |
Average Volume 20d | 56.9k |
What is the price of JWEL stocks?
As of December 21, 2024, the stock is trading at CAD 37.34 with a total of 49,520 shares traded.
Over the past week, the price has changed by +3.51%, over one month by +7.59%, over three months by +11.84% and over the past year by +27.99%.
As of December 21, 2024, the stock is trading at CAD 37.34 with a total of 49,520 shares traded.
Over the past week, the price has changed by +3.51%, over one month by +7.59%, over three months by +11.84% and over the past year by +27.99%.
Is Jamieson Wellness a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Jamieson Wellness (TO:JWEL) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 52.62 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of JWEL as of December 2024 is 36.09. This means that JWEL is currently overvalued and has a potential downside of -3.35%.
Partly, yes. Based on ValueRay Fundamental Analyses, Jamieson Wellness (TO:JWEL) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 52.62 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of JWEL as of December 2024 is 36.09. This means that JWEL is currently overvalued and has a potential downside of -3.35%.
Is JWEL a buy, sell or hold?
Jamieson Wellness has no consensus analysts rating.
Jamieson Wellness has no consensus analysts rating.
What are the forecast for JWEL stock price target?
According to ValueRays Forecast Model, JWEL Jamieson Wellness will be worth about 39.1 in December 2025. The stock is currently trading at 37.34. This means that the stock has a potential upside of +4.82%.
According to ValueRays Forecast Model, JWEL Jamieson Wellness will be worth about 39.1 in December 2025. The stock is currently trading at 37.34. This means that the stock has a potential upside of +4.82%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 40.8 | 9.3% |
Analysts Target Price | - | - |
ValueRay Target Price | 39.1 | 4.8% |